In this prospective longitudinal study of women with ovarian tumors, we demonstrate a local presence and activity of the IGF system in ascites that differs substantially from that of the circulating IGF system, and furthermore, show the potential of IGF-1, IGF-2, and PAPP-A2 in predicting patient outcomes. This evidence concerns the gene IGF1 and ovarian neoplasm.